Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Public Comment Sought on CDC's Vaccine Safety
In consultation with outside stakeholders, the CDC has undertaken a review of vaccine safety activities at CDC. As part of this effort, the CDC is seeking public comments
regarding the current state of the agency's vaccine safety
program and to identify ways in which excellence in vaccine safety monitoring, research and communication can be maximized and sustained in the future. Comments should focus on the objectives listed below:
1) Review the structure, function, credibility, effectiveness, efficiency and support of CDC's vaccine safety program
and assess how it can be maximized and sustained.
Assess the program's ability to detect emerging or rare adverse events.
Assess the capacity of the program to provide comprehensive monitoring of the growing number of vaccines.
2) Review the intramural and extramural collaborative
activities of the vaccine safety program and determine
their effectiveness and efficiency.
Assess additional steps CDC can institute to enhance coordination with other federal agencies and partners,
including consumer and advocacy groups.
3) Determine the optimal organizational location for vaccine safety activities within the CDC to ensure
scientific objectivity, transparency and oversight while at the same time ensuring that program priorities are appropriately established and are relevant to the immunization program and other stakeholder needs.
CDC will post presentations of facts about CDC's vaccine safety activities on the CDC Web site so that the public can
make informed comments about the objectives listed above. The link to the objectives is at
http://www.cdc.gov/od/vaccsafe/comments.htm. The links to the presentations are also provided on the Web site.
We invite the public to review the available information and follow the instructions for providing comments and input. The public comment period will end on October 12, 2004.
If you have any questions or need more information, please email the following address:
vaccsafe@cdc.gov.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
